HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Seth M Steinberg Selected Research

VA 061 (VA061)

12/2008Association of the ABCG2 C421A polymorphism with prostate cancer risk and survival.
1/2008A phase II clinical trial of sorafenib in androgen-independent prostate cancer.
12/2007Lack of prognostic significance of prostate biopsies in metastatic androgen independent prostate cancer.
5/2007Pre-clinical and clinical evaluation of estramustine, docetaxel and thalidomide combination in androgen-independent prostate cancer.
11/2005Polymorphism in the hypoxia-inducible factor 1alpha gene may confer susceptibility to androgen-independent prostate cancer.
10/2005A phase II study of perifosine in androgen independent prostate cancer.
3/2005A randomized, phase II trial of ketoconazole plus alendronate versus ketoconazole alone in patients with androgen independent prostate cancer and bone metastases.
7/2004Randomized phase II trial of docetaxel plus thalidomide in androgen-independent prostate cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Seth M Steinberg Research Topics

Disease

173Neoplasms (Cancer)
11/2022 - 01/2002
43Prostatic Neoplasms (Prostate Cancer)
01/2021 - 10/2002
40Breast Neoplasms (Breast Cancer)
01/2021 - 12/2002
31Neoplasm Metastasis (Metastasis)
01/2020 - 08/2002
21Disease Progression
11/2022 - 02/2006
17Neutropenia
12/2021 - 08/2004
17Ovarian Neoplasms (Ovarian Cancer)
10/2020 - 01/2003
17Melanoma (Melanoma, Malignant)
11/2017 - 01/2002
13Lymphoma (Lymphomas)
11/2021 - 04/2002
13Brain Neoplasms (Brain Tumor)
05/2020 - 01/2002
13Renal Cell Carcinoma (Grawitz Tumor)
10/2015 - 01/2002
12Mesothelioma
10/2021 - 12/2003
11Carcinoma (Carcinomatosis)
11/2022 - 05/2008
11Kaposi Sarcoma (Kaposi's Sarcoma)
03/2022 - 01/2007
10Graft vs Host Disease (Graft-Versus-Host Disease)
01/2020 - 03/2003
9Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
04/2022 - 12/2006
9Bronchiolitis Obliterans Syndrome
01/2022 - 05/2010
9B-Cell Lymphoma (Lymphoma, B Cell)
01/2020 - 04/2002
8Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2022 - 06/2008
8Hematologic Neoplasms (Hematological Malignancy)
12/2021 - 03/2004
8Vaccinia
05/2012 - 10/2002
7Neurofibromatosis 1 (Neurofibromatosis Type I)
11/2022 - 05/2014
7Colorectal Neoplasms (Colorectal Cancer)
11/2022 - 07/2009
7Infections
12/2021 - 02/2007
7Fatigue
12/2021 - 05/2002
7Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2020 - 01/2006
7Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
01/2018 - 05/2003
7Ovarian Epithelial Carcinoma
01/2011 - 12/2003
6Plexiform Neurofibroma
11/2022 - 05/2014
6Adenocarcinoma
01/2021 - 05/2011
6Lung Neoplasms (Lung Cancer)
01/2021 - 01/2008
6Diarrhea
01/2020 - 05/2002
6Sarcoma (Soft Tissue Sarcoma)
01/2016 - 02/2007
6Inflammatory Breast Neoplasms
05/2011 - 12/2002
5Leukemia
01/2022 - 07/2014
5Residual Neoplasm
01/2022 - 06/2005
5Multiple Myeloma
11/2021 - 09/2015
5Malignant Mesothelioma
10/2021 - 11/2014
5Pancreatic Neoplasms (Pancreatic Cancer)
01/2021 - 05/2010
5Acquired Immunodeficiency Syndrome (AIDS)
11/2017 - 06/2003
5Hypoxia (Hypoxemia)
08/2017 - 11/2005
5T-Cell Lymphoma (Lymphoma, T Cell)
07/2015 - 06/2006
5Neoplasm Micrometastasis
06/2013 - 07/2003
5Peripheral Nervous System Diseases (PNS Diseases)
03/2010 - 07/2005

Drug/Important Bio-Agent (IBA)

30Biomarkers (Surrogate Marker)IBA
11/2022 - 12/2002
28VaccinesIBA
11/2022 - 10/2002
25Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2022 - 04/2002
24Pharmaceutical PreparationsIBA
01/2020 - 04/2002
19Docetaxel (Taxotere)FDA Link
01/2021 - 07/2004
19Proteins (Proteins, Gene)FDA Link
01/2020 - 05/2005
17Bevacizumab (Avastin)FDA Link
11/2022 - 07/2003
17AntigensIBA
12/2021 - 05/2003
17Doxorubicin (Adriamycin)FDA LinkGeneric
01/2020 - 04/2002
15Prednisone (Sone)FDA LinkGeneric
01/2021 - 04/2002
15AndrogensIBA
03/2009 - 10/2002
14Prostate-Specific Antigen (Semenogelase)IBA
01/2020 - 10/2002
13Rituximab (Mabthera)FDA Link
12/2021 - 06/2008
13Etoposide (VP 16)FDA LinkGeneric
01/2020 - 04/2002
11CytokinesIBA
01/2022 - 08/2002
11Vincristine (Oncovin)FDA LinkGeneric
01/2020 - 04/2002
11Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2019 - 10/2002
10Immune Checkpoint InhibitorsIBA
01/2022 - 11/2017
10Phosphotransferases (Kinase)IBA
01/2021 - 04/2007
10Sorafenib (BAY 43-9006)FDA Link
10/2020 - 01/2008
10Paclitaxel (Taxol)FDA LinkGeneric
01/2019 - 12/2003
9MesothelinIBA
11/2020 - 08/2006
9ErbB Receptors (EGF Receptor)IBA
10/2016 - 08/2004
9Interleukin-2 (IL2)IBA
02/2014 - 01/2002
8PlatinumIBA
12/2021 - 01/2015
8Immunotoxins (Immunotoxin)IBA
11/2020 - 08/2006
8Histone Deacetylase InhibitorsIBA
01/2020 - 06/2006
8DNA (Deoxyribonucleic Acid)IBA
01/2020 - 05/2002
8romidepsin (FK228)FDA Link
07/2015 - 06/2006
8VA 061 (VA061)IBA
12/2008 - 07/2004
7Chimeric Antigen ReceptorsIBA
04/2022 - 02/2015
7Biological ProductsIBA
12/2021 - 08/2004
7Cisplatin (Platino)FDA LinkGeneric
04/2016 - 12/2003
6Hormones (Hormone)IBA
01/2021 - 05/2005
6Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2020 - 06/2009
6Peptides (Polypeptides)IBA
08/2016 - 11/2005
6DepsipeptidesIBA
06/2011 - 11/2002
6Thalidomide (Thalomid)FDA Link
04/2010 - 07/2004
5cabozantinibIBA
01/2022 - 09/2015
5Lenalidomide (CC 5013)FDA Link
11/2021 - 09/2015
5Dexamethasone (Maxidex)FDA LinkGeneric
11/2021 - 09/2015
5olaparibIBA
10/2021 - 01/2012
5PROSTVACIBA
01/2020 - 05/2012
5Messenger RNA (mRNA)IBA
01/2016 - 05/2007
5Cancer VaccinesIBA
11/2015 - 05/2005
5Melphalan (Alkeran)FDA LinkGeneric
05/2012 - 12/2003

Therapy/Procedure

120Therapeutics
01/2022 - 01/2002
59Drug Therapy (Chemotherapy)
12/2021 - 01/2002
18Immunotherapy
11/2022 - 01/2002
17Hematopoietic Stem Cell Transplantation
01/2022 - 03/2003
16Castration
01/2021 - 07/2008
13Radiotherapy
01/2021 - 08/2003
9Aftercare (After-Treatment)
10/2013 - 08/2004
6Transplantation
01/2022 - 03/2003
6Neoadjuvant Therapy
06/2018 - 01/2008
5Cell Transplantation
01/2022 - 02/2009